Plasma Insulin Responses to Glucose and Tolbutamide of Normal Weight and Obese Diabetic and Nondiabetic Subjects

Plasma insulin responses to oral glucose (100 gm.) and intravenous tolbutamide (1.0 gm.) before and after dexamethasone were determined in normal, obese nondiabetic, normal-weight diabetic and obese diabetic subjects. Fasting plasma insulin levels were significantly higher in obese nondiabetic and obese diabetic subjects than in normalweight nondiabetic and diabetic individuals. Total plasma insulin response to oral glucose in obese nondiabetics was threefold greater, in obese diabetic 2.2-fold greater, and in normal-weight diabetics 1.7-fold greater than that observed in normal individuals. When the plasma insulin responses of obese diabetic and nondiabetic subjects were measured at comparable blood sugar levellN insulin secretion was demonstrated to be significantly impaired in the diabetic group. The initial plasma insulin response (i.e., thirty-minute level) to glucose of diabetic subjects is markedly impaired when compared to normal-weight and obese nondiabetic individuals. Total plasma insulin response to intravenous tolbutamide was fourfold greater in obese nondiabetic and obese diabetic subjects than in normal-weight nondiabetic and diabetic individuals. Following dexamethasone (2 mg. q.i.d. × 2), plasma insulin response to intravenous tolbutamide was increased fivefold in normal subjects, threefold in obese nondiabetics, 1.6-fold in obese diabetics and twofold in nonobese diabetics. The results of these studies indicate that obesity is associated with a hypersecretory insulin response to both tolbutamide and glucose. The presence of overt diabetes melitus indicates an impairment in insulin response in both obese and nonobese individuals when compared to their appropriate nondiabetic controls. Dexamethasone provokes a marked compensatory insulin response in nondiabetics and makes more apparent the impaired secretory capacity of diabetic subjects. Maturity-onset diabetes in nonobaese individuals appears to be a consequence primarily of insulin deficiency. In obese diabetic individuals, however, even though secretory capacity may be significantly greater than observed in nonobese diabetics, impaired carbohydrate tolerance develops because insulin antagonism associated with obesity per se.

[1]  N. Mcintyre,et al.  Intestinal factors in the control of insulin secretion. , 1965, The Journal of clinical endocrinology and metabolism.

[2]  S. Berson,et al.  Plasma Insulin Concentrations in Nondiabetic and Early Diabetic Subjects: Determinations by a New Sensitive Immuno-assay Technic , 1960, Diabetes.

[3]  G. Grodsky,et al.  CRITICAL FACTORS IN EXCESSIVE SERUM-INSULIN RESPONSE TO GLUCOSE. OBESITY IN MATURITY-ONSET DIABETES AND GROWTH HORMONE IN ACROMEGALY. , 1965, Lancet.

[4]  G. Grodsky,et al.  Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay , 1963, Diabetes.

[5]  H. Seltzer,et al.  Exhaustion of Insulogenic Reserve in Maturity-onset Diabetic Patients During Prolonged and Continuous Hyperglycemic Stress , 1964, Diabetes.

[6]  Plasma insulin in normal late pregnancy. , 1963, The New England journal of medicine.

[7]  E. H. Ahrens,et al.  CARBOHYDRATE METABOLISM IN TWO FORMS OF HYPERGLYCERIDEMIA. , 1964, The Journal of clinical investigation.

[8]  J. Vallance-Owen.  Synalbumin insulin antagonism. , 1964, Postgraduate medical journal.

[9]  R. Bregant,et al.  Observations on Blood Glucose Concentration of Human Subjects During Continuous Sampling , 1965, Diabetes.

[10]  J. Roth,et al.  PLASMA INSULIN AND GROWTH HORMONE LEVELS IN OBESITY AND DIABETES , 1965, Annals of the New York Academy of Sciences.

[11]  S. Fajans,et al.  PLASMA INSULIN IN ORGANIC HYPERINSULINISM: COMPARATIVE EFFECTS OF TOLBUTAMIDE, LEUCINE AND GLUCOSE. , 1964, The Journal of clinical endocrinology and metabolism.

[12]  G. Kessler,et al.  CONTINUOUS IN VIVO DETERMINATION OF BLOOD GLUCOSE IN HUMAN SUBJECTS , 1960, Annals of the New York Academy of Sciences.

[13]  H. Elrick,et al.  PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION. , 1964, The Journal of clinical endocrinology and metabolism.

[14]  D. Kipnis,et al.  Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. , 1965, The Journal of laboratory and clinical medicine.

[15]  Yalow Rs,et al.  THE PRESENT STATUS OF INSULIN ANTAGONISTS IN PLASMA: OCTOBER 1963. , 1964 .

[16]  C. Weller,et al.  Continuous blood glucose measurements in diabetics given phenformin timed-disintegration capsules. , 1961, Metabolism: clinical and experimental.

[17]  D. Kipnis,et al.  STUDIES OF INSULIN AND GROWTH HORMONE SECRETION IN HUMAN OBESITY. , 1964, The Journal of laboratory and clinical medicine.

[18]  G. Grodsky,et al.  Reduction by phenformin of excessive insulin levels after glucose loading in obese and diabetic subjects. , 1963, Metabolism: clinical and experimental.

[19]  D. Kipnis,et al.  DIABETOGENIC FACTORS ASSOCIATED WITH PREGNANCY. , 1964, Transactions of the Association of American Physicians.